Laszig, S., Diederichs, A., Salzmann-Manrique, E., Schuschel, K., Gonçalves-Dias, J., Issa, H., Miladinovic, M., Rettinger, E., Wehner, S., Kreyenberg, H., Bremm, M., Hünecke, S., Kerp, H., Waack-Buchholz, K., Thol, F., Goemans, B. F., Moerloose, B. D., Boztug, H., Scheidegger, N., Pawińska-Wąsikowska, K., Reinhardt, D., Klusmann, J. (2026). CPX-351 in Down syndrome–associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial. Blood. https://doi.org/10.1182/blood.2025030775